Skip to main content

Ayanin

ADVERTISEMENT
Identification
Molecular formula
C13H10O5
CAS number
null
IUPAC name
2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one
State
State

At room temperature, Ayanin is a solid with a crystalline structure. It has limited solubility in water but can dissolve in organic solvents like ethanol and dimethyl sulfoxide (DMSO). Its stability is moderate under ambient conditions, and it must be protected from direct light exposure.

Melting point (Celsius)
140.00
Melting point (Kelvin)
413.15
Boiling point (Celsius)
651.50
Boiling point (Kelvin)
924.65
General information
Molecular weight
322.28g/mol
Molar mass
322.2780g/mol
Density
1.5600g/cm3
Appearence

Ayanin appears as a light yellow crystalline solid. It is typically used in its pure form for research and development purposes. This compound is sensitive to air and light, which may cause it to degrade over time, requiring careful storage conditions to maintain its stability.

Comment on solubility

Solubility of 2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one

The solubility of 2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one (C13H10O5) can be influenced by several factors due to its chemical structure, which incorporates multiple hydroxyl (-OH) groups. Here are some key points to consider:

  • Polarity: The presence of hydroxyl groups generally increases polarity, which, in turn, can enhance solubility in polar solvents such as water.
  • Hydrogen Bonding: The ability of hydroxyl groups to form hydrogen bonds can promote solubility in aqueous environments, making it likely soluble in water.
  • Solvent Compatibility: This compound may also exhibit solubility in organic solvents, particularly those that can engage in similar types of intermolecular interactions.
  • Temperature Dependency: Like many organic compounds, solubility may vary with temperature; increased temperatures typically lead to increased solubility.

In summary, while there is a strong suggestion that 2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one is soluble in polar solvents, the exact solubility will be contingent upon the specific conditions, including the solvent used and temperature. Therefore, experimental data would be beneficial for a definitive understanding.

Interesting facts

Interesting Facts about 2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one

This intriguing compound, known for its unique structure and potential applications, belongs to a class of organic compounds called polyphenols. It has garnered significant interest within the fields of chemistry and pharmacology due to its promising biological properties.

Key Properties and Applications

  • Antioxidant Activity: This compound exhibits potent antioxidant properties, making it a candidate for protecting cells from oxidative stress.
  • Anti-inflammatory Effects: There is growing evidence suggesting its potential in attenuating inflammatory responses, which could be beneficial in various therapeutic applications.
  • Pharmaceutical Potential: Researchers are investigating its use in developing new drugs for diseases such as cancer and neurodegenerative disorders.

Chemical Structure Insights

The structure of this compound features a pyran-4-one framework, which is pivotal in contributing to its bioactivity. The presence of hydroxy substituents enhances its reactivity and solubility, which are critical for biological interactions.

Research Directions

Ongoing studies aim to further elucidate the molecular mechanisms at play, exploring questions such as:

  1. How does its structure influence its bioactivity?
  2. What are the most effective applications in medicine?
  3. Can it be successfully synthesized in a cost-effective manner for industrial use?

As a compound with multifaceted implications for health and science, 2-[2-(3,4-dihydroxyphenyl)vinyl]-6-hydroxy-pyran-4-one represents a captivating area of research within modern chemistry. Its potential applications may open new avenues for treatment and prevention of various diseases, making it a key player in future pharmaceutical developments.